SUMMARY -Th e aim of this study was to evaluate the implementation of the 9 th edition of the American College of Chest Physicians (ACCP9) guidelines for prevention of venous thromboembolism in nonsurgical patients in clinical practice in one university and one general Croatian hospital. A retrospective study was conducted at Zadar General Hospital from Zadar and Dubrava University Hospital from Zagreb. Medical charts of all patients admitted to Medical Departments in two periods, before and after implementation of the ACCP9 guidelines, were analyzed. Th e ACCP9 guidelines were made available to all physicians through the hospital electronic information system immediately after the publication. Th e Hospital Drug Committees promoted implementation of the guidelines during their periodical clinical visits. Overall, 850 patients were included in the study in two periods. Th ere was no statistically signifi cant diff erence in the number of high-risk patients receiving thromboprophylaxis after the guidelines implementation in either hospital. In both periods, a significantly higher number of high-risk patients received thromboprophylaxis in Dubrava University Hospital in comparison with Zadar General Hospital (31.7% vs. 3.8% and 40.3% vs. 7.3%, respectively; p<0.001). Th is study revealed insuffi cient implementation of evidence-based thromboprophylaxis guidelines in clinical practice in two Croatian hospitals.
Introduction
Venous thromboembolism (VTE) comprises deep vein thrombosis (DVT) and pulmonary embolism (PE). It is an important cause of morbidity and mortality in hospitalized patients, and treatment of VTE and related long-term morbidities is associated with considerable costs to the health care system 1,2 . Pulmonary embolism, which is the most serious complication of VTE, is the third most common lifethreatening cardiovascular disease, after myocardial infarction and stroke 3 . It accounts for 5%-10% of deaths in hospitalized patients, making PE the most common preventable cause of in-hospital deaths 4 . Th e exact incidence of VTE is diffi cult to estimate because it is often asymptomatic and unrecognized. Th e inci-dence varies, ranging from 76 to 117 cases/100,000 patients [5] [6] [7] in the US, and from 160 to 180 cases/100,000 patients in Europe 8, 9 . Although VTE is often regarded as a surgical complication, about threequarters of hospitalized patients who suff er a fatal PE are, in fact, medical patients 10 . Th e eff ectiveness and safety of thromboprophylaxis has been supported by the evidence from several randomized clinical trials conducted in medical patients [11] [12] [13] . However, underuse of routine thromboprophylaxis has been reported. Th ree large-scale prevention studies ENDORSE, IMPROVE and DVT-FREE showed that appropriate thromboprophylaxis rates in at-risk medical patients varied from 39.5% to 60.0% and that thromboprophylaxis rates in surgical patients were higher than in medical patients [14] [15] [16] . Th romboprophylaxis in clinical practice can be improved by the implementation of guidelines for the risk assessment and prevention of VTE. However, there are always physicians who do not apply the guidelines consistently 17 . Th e American College of Chest Physicians (ACCP) guidelines for prevention of VTE in nonsurgical patients include recommendations for the risk assessment and prevention of VTE in medical patients 18 . Th e 9 th edition (ACCP9) of the guidelines was published in February 2012 and their implementation in clinical practice has not yet been evaluated.
Th e aim of the study was to evaluate the implementation of ACCP9 guidelines in clinical practice in two Croatian hospitals, one university and one general.
Patients and Methods

Study design and setting
A retrospective study was conducted at two Croatian hospitals, Zadar General Hospital from Zadar and Dubrava University Hospital from Zagreb. Th e former is a non-teaching hospital with 500 beds; the latter is a university-based teaching hospital with 1000 beds. Th ese hospitals were chosen because of the possible diff erence in clinical practice between university and general hospitals.
Th e study was approved by the research Ethics Committees of the Zadar General Hospital and Dubrava University Hospital.
Guideline distribution
Th e ACCP9 guidelines for prevention of VTE in nonsurgical patients were published in February 2012. Immediately after the publication, the guidelines became available to all physicians in Zadar General Hospital and Dubrava University Hospital via hospital electronic information system. Each hospital has a Hospital Drug Committee, which evaluates and promotes the rational use of drugs. Th e Committee members periodically conduct clinical visits, during which they discuss therapeutic issues with hospital physicians. After distribution of the ACCP9 guidelines, the Hospital Drug Committee evaluated the use of thromboprophylaxis and promoted the implementation of the guidelines during their periodical clinical visits, which took place approximately every three months. Medical records of hospitalized patients were evaluated during the visit and guideline implementation issues were discussed with physicians.
Data collection
We evaluated medical charts of all patients admitted to the Medical Departments of the Zadar General Hospital and Dubrava University Hospital between January 1 and January 31, 2012, i.e. in the period before the implementation of the guidelines, and between January 1 and January 31, 2013, i.e. in the period after the implementation of the guidelines. For each patient included in the study, we collected data on the assessment of the VTE risk (presence of an active cancer, previous VTE, reduced mobility, known thrombophilic condition, recent (≤1 month) trauma and/or surgery, older age (≥70 years), heart and/or respiratory failure, acute myocardial infarction or ischemic stroke, acute infection and/or rheumatologic disorder, obesity (BMI ≥30), and ongoing hormonal treatment) 18 . Data were entered into an electronic database developed by the researchers for use in the study.
We excluded from the study medical charts of the patients that had an indication for anticoagulation therapy (e.g., DVT, atrial fi brillation) and patients that had an excessive risk of bleeding as defi ned by the ACCP9 guidelines (active gastroduodenal ulcer, bleeding in 3 months before admission, platelet count <50x10 9 /L, and multiple risk factors for bleeding) 18 .
Risk assessment model
In order to assess the VTE risk and to determine adequacy of thromboprophylaxis, the ACCP9 guidelines for prevention of VTE in nonsurgical patients were used 18 . Th e guidelines have adopted the Padua Prediction Score risk assessment model, which is based on the principle of assigning points to each of the 11 common VTE risk factors 19 . Using this model, we categorized study patients in two groups: low-risk (score <4) and high-risk (score ≥4) patients.
We reviewed medical charts to identify the use of thromboprophylaxis during hospitalization and to determine whether the study patients were receiving appropriate thromboprophylaxis. For high-risk medical patients, the ACCP9 guidelines recommend the VTE prophylaxis with low molecular weight heparin, low dose unfractionated heparin or fondaparinux. For low-risk medical patients, no thromboprophylaxis is recommended 18 .
Statistical analysis
We determined the proportion of high-risk and low-risk patients and the proportion of patients receiving adequate prophylaxis. Th e χ 2 -test was used to test diff erences between categorical variables. Th e values of p<0.05 were considered statistically signifi cant. All tabulations and statistical analyses were done using Statistica version 5.5 for Windows (StatSoft Inc. Tulsa, OK, USA).
Results
Medical charts of 204 patients admitted in January 2012 and of 216 patients admitted in January 2013 to the Medical Department of Dubrava University Hospital were included in the study (Table 1) . Th ere was no statistically signifi cant diff erence in the number of high-risk patients receiving thromboprophylaxis between the two study periods. However, a signifi cantly higher number of low-risk patients received prophylaxis in January 2013.
We included in the study medical charts of 224 patients admitted in January 2012 and of 206 patients admitted in January 2013 to the Medical Department of Zadar General Hospital (Table 2) . Th ere was no statistically signifi cant diff erence in the number of pa- tients receiving thromboprophylaxis between the January 2012 and January 2013 study periods.
In both periods, high-risk medical patients received thromboprophylaxis signifi cantly more often in Dubrava University Hospital than in Zadar General Hospital (Table 3) .
Discussion
To the authors' knowledge, this is the fi rst study evaluating the implementation of the ACCP9 guidelines in clinical practice. Th e results indicated that the implementation of the guidelines through the hospital information system and with support of the Hospital Drug Committee did not improve the thromboprophylaxis rate in high-risk medical patients in two Croatian hospitals. Previous studies have also reported insuffi cient implementation of thromboprophylaxis guidelines. In the study by Amin et al., only 9.8% of medical patients received thromboprophylaxis in accordance with the guidelines 20 . Obviously, the stricter and immediate education of physicians is needed to overcome the implementation gap 21 . Educational programs have been eff ective in increasing the rate of thromboprophylaxis 22 . Surprisingly enough, in Dubrava University Hospital, signifi cantly more low-risk medical patients received thromboprophylaxis after the implementation of the guidelines. Th is could be the result of physicians' misunderstanding of the guidelines and having difficulties with risk assessment in medical patients. Since the assessment of VTE risk is simpler in surgical patients, it could result in a higher rate of thromboprophylaxis compared with medical patients [14] [15] [16] . Alarmingly high proportions of high-risk medical patients did not receive thromboprophylaxis. Th ese proportions were higher than those reported in previous studies [14] [15] [16] . Th is could be attributed to diff erences in clinical practice standards and physician education in diff erent countries.
In both study periods, the number of high-risk medical patients receiving thromboprophylaxis was signifi cantly higher in Dubrava University Hospital than in Zadar General Hospital. Th is diff erence was probably the result of greater fi nancial resources and better educated physicians in university hospitals. Our results are consistent with the studies conducted in Canada and the USA by Kahn et al. 23 and Amin et al. 24 , who also report greater use of thromboprophylaxis in university hospitals. Other studies did not detect such diff erence [14] [15] [16] .
Strengths and limitations
Th e strength of our study was that we evaluated the implementation of the guidelines in one university hospital and one general hospital. Th is allowed us to limit the potential bias due to diff erences in clinical practice, physicians' knowledge, and so on.
Th e fi rst limitation of our study was the limited quality of collected data due to its retrospective design. For instance, it was not possible to evaluate if the duration of thromboprophylaxis was in accordance with the guidelines, since changes in patient mobility could not be assessed from their medical charts. Another limitation was that we could not control the use of alternative guidelines or standards for thromboprophylaxis, which could have infl uenced the study results. Also, our study included only two hospitals and the rate of thromboprophylaxis is likely to vary across the hospitals because of the diff erence in local standards and knowledge. Th erefore, the results of our study should be interpreted having these limitations in mind. Th is study demonstrated insuffi cient implementation of evidence-based thromboprophylaxis guidelines in clinical practice and signifi cant diff erence between university and general hospitals. Up to more than half of hospitalized medical patients were at a high risk of VTE, but only up to one-third of them received thromboprophylaxis. Th e proportion of patients receiving thromboprophylaxis did not signifi cantly increase after the implementation of the ACCP9 guidelines. Underuse of VTE prophylaxis will certainly increase in-hospital mortality. To improve patient safety, more eff ort is needed to increase the extent of implementation of the current thromboprophylaxis guidelines 25 .
